{
  "docId": "019de074-7a94-707c-b002-278357aaec02",
  "docSlug": "fb2ab974265a0e95c40d5a8a75128cd1",
  "documentTitle": "BenevolentAI | Results Presentation Deck | 38 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 38,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "propose_solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a treatment flow diagram to show where BEN-2293 fits relative to existing therapies.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-7a94-707c-b002-278357aaec02/16",
  "deckHref": "/decks/019de074-7a94-707c-b002-278357aaec02",
  "deckJsonHref": "/decks/019de074-7a94-707c-b002-278357aaec02.json",
  "deckAnchorHref": "/decks/019de074-7a94-707c-b002-278357aaec02#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.44,
        "x": 0.53,
        "y": 0.77
      },
      "kind": "callout",
      "text": "BEN-2293 will target Mild, Moderate and Severe AD patients, addressing unmet need as a steroid sparing alternative...",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d49ac23e-6032-4645-bf93-4cdec2ba3980",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.4,
        "x": 0.55,
        "y": 0.05
      },
      "kind": "diagram",
      "text": "Atopic Dermatitis Treatment Paradigm",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d829d311-a95f-43a3-b89f-2bea301c823a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.04,
        "y": 0.23
      },
      "kind": "paragraph",
      "text": "Atopic dermatitis (AD) is the most common chronic inflammatory skin disease... BEN-2293 is expected to treat atopic dermatitis by: inhibiting itch signaling and blocking nerve sensitization...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4a3621d9-0929-4360-8c33-6eebc1ab9fe3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.02,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "Sources: (1) Weidinger et al. Nat Rev Dis Primers 2018; (2) GlobalData Report 2018...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a64f326-93d8-4574-9d9c-c1d5daf072c7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.03,
        "y": 0.07
      },
      "kind": "title",
      "text": "BEN-2293 for Atopic Dermatitis",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c89789b9-9657-4218-83d6-4e477f81e3f6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "customer-journey-map",
      "slug": null,
      "matchId": "f6ea3d45-95d1-4ea3-a90e-2f9a8c956b8d",
      "evidence": "The treatment paradigm diagram maps the patient/treatment flow across disease severity stages.",
      "confidence": 0.7
    }
  ],
  "arcBeats": [
    {
      "to": 18,
      "from": 16,
      "beatId": "822e78e8-50fd-475a-bfd8-2fe75d826127",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The section on BEN-2293 for Atopic Dermatitis presents a solution to the problem.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 18,
      "from": 16,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "05a47cba-105a-42ab-85c9-7caabd763d6d",
      "evidence": "The section on BEN-2293 presents a potential quick win.",
      "position": 1,
      "objective": "Can BEN-2293 provide a quick win in Atopic Dermatitis?",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}